Breaking news – Pagina 206 – AMD

Breaking news

Novembre 15, 2022 Alice Lione

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial

Succurro E ,Vizza P, Papa, et al.
Diabetes Obes Metab. 2022;24(12):2319-2330.

Leggi

Novembre 15, 2022 Alice Lione

The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes

Thomas NJ, Walkey HC, Kaur A, et al.
Diabetologia. Pub. online 10 Nov 2022.

Leggi

Novembre 10, 2022 Alice Lione

Atrial fibrillation and dapagliflozin efficacy in patients with preserved or mildly reduced ejection fraction

Butt JH, Kondo T, Jhund PS, et al.
J Am Coll Cardiol. 2022;80(18):1705–1717.

Leggi

Novembre 15, 2022 Alice Lione

The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

Khunti K, Aroda VR, Aschner P, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00278-9.

Leggi

Novembre 10, 2022 Alice Lione

An assessment of clinical continuous glucose monitoring targets for older and high-risk people living with type 1 diabetes

O’Neal DN, Cohen O, Vogrin S, et al.
Diabetes Technol Ther. Pub. online 31 Oct 2022

Leggi

Novembre 10, 2022 Alice Lione

Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease

Retnakaran R, Shah BR
BMC Med. 2022;20(1):389.

Leggi

Novembre 10, 2022 Alice Lione

Improved effectiveness of immediate continuous glucose monitoring in hypoglycemia-prone people with type 1 diabetes compared with hypoglycemia-focused psycho-education following a previous structured education: a randomised controlled trial

Serné E, van den Berg IK, Racca C, et al.
Diabetes Technol Ther. Pub. online 3 Nov 2022

Leggi

Novembre 4, 2022 dario.olivero

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

Urva S, Coskun T, Loh MT, et al.
The Lancet. Pub. online 27 Oct 2022.

Leggi

Novembre 4, 2022 dario.olivero

Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation Consortium: the CIT-08 study

Rickels MR, Eggerman TL, Bayman L, et al.
Diabetes Care. 2022;dc212688

Leggi

Novembre 2, 2022 Alice Lione

Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes

Shah NV, Akturk HK, Vigers T, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.

Leggi